PMC:7441777 / 4134-4325 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T25","span":{"begin":58,"end":63},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"}],"text":"ntial therapeutic strategy without risk of crosstalk with human polymerases (Borgio et al., 2020; Subissi et al., 2014; Zhai et al., 2005). Very recently, Yin et al. reported the crystal stru"}

{"project":"LitCovid-PubTator","denotations":[{"id":"179","span":{"begin":58,"end":63},"obj":"Species"}],"attributes":[{"id":"A179","pred":"tao:has_database_id","subj":"179","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ntial therapeutic strategy without risk of crosstalk with human polymerases (Borgio et al., 2020; Subissi et al., 2014; Zhai et al., 2005). Very recently, Yin et al. reported the crystal stru"}

{"project":"2_test","denotations":[{"id":"32720577-32399096-56195091","span":{"begin":92,"end":96},"obj":"32399096"},{"id":"32720577-25197083-56195092","span":{"begin":114,"end":118},"obj":"25197083"}],"text":"ntial therapeutic strategy without risk of crosstalk with human polymerases (Borgio et al., 2020; Subissi et al., 2014; Zhai et al., 2005). Very recently, Yin et al. reported the crystal stru"}